Clinical Trial Update: A Comparison of PF708 and Forteo in Osteoporosis Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating the comparison of PF708 versus Forteo (teriparatide) in patients with osteoporosis; the study sponsored by Pfenex, Inc. has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Forteo (teriparatide)
• PF708 (teriparatide biosimilar)

Snippet

Sponsor: Pfenex, Inc | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED